Childhood obesity is rapidly increasing in developing nations, creating a significant health challenge. This epidemic is now outpacing unde...

The breach adds to a ⁠growing number ⁠of cyberattacks on the healthcare sector, including medical device makers Abbott, Stryker Medtronic a...

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...

Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...

The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...

Eli Lilly has launched its oral weight management pill Foundayo in the United Kingdom. This new treatment, chemically known as orforglipron...

Nestle is developing specialized products for GLP-1 weight-loss drug users. Artificial intelligence aids in analyzing research and identify...

The Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...

Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...

Britain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...

On Friday, Europe's STOXX 600 index marked its fourth consecutive record closing, driven primarily by technology stocks that mirrored the s...

School Assembly News Headlines: The Lok Sabha in India has successfully passed a significant bill aimed at modernizing banking evidence law...

European stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...

Novo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...

On July 29, Amgen determined the incident was material, based ⁠on ⁠its evaluation of how many files appeared to be affected and the possibi...

Novo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...

Novo Nordisk has sued Eli Lilly in a U.S. court. The Danish company accuses Lilly of false advertising for its weight-loss medicines. Novo ...